Our Digital Offering
Healthcare organisations and Pharmaceutical companies are implementing innovative digital health strategies. Covid-19 has accelerated the need to integrate this technologies, but there are several structural (IT) and measurement (outcomes) challenges that both pharmaceutical companies and regulators are facing. Since 2017, we have been working with companies and liaising with NICE/EMA on these topics.
We assist in creating strategies with any kind of SaS, whether CRM, EHRs, DTC, machine learning, AI, or other technologies, leading organizations can fundamentally change the way healthcare is delivered and the health consumer experience.
We at BFI have been working for Health Tech Startups since 2016.
We understand the complex Routes to Market, the need of Regulators and the difficulties that Pharmaceutical companies face when dealing with digital health technologies.
Covid-19 has accelerated the need to integrate and understand advance data analysis and softwares to improve outcomes, both in healthcare and in the pharmaceutical industry